Bristol-Myers Squibb (BMY) Announces U.S. FDA Acceptance of Opdivo sBLA fro cHL Following Therapies – StreetInsider.com

Bristol-Myers Squibb (BMY) Announces U.S. FDA Acceptance of Opdivo sBLA fro cHL Following Therapies – StreetInsider.com

Bristol-Myers Squibb (BMY) Announces U.S. FDA Acceptance of Opdivo sBLA fro cHL Following Therapies – StreetInsider.com
Published on 2016-04-14